Answer
Sebetralstat competitively and reversibly inhibits plasma kallikrein, blocking bradykinin production and subsequent bradykinin-receptor activation, thereby halting progression of hereditary angioedema attacks.
Sources for this answer
- Ekterly 300 mg film-coated tabletsKalVista Pharmaceuticals Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 2Document updated
Sources checked